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Inactivation of the ARF-p53 tumor suppressor pathway leads to immortalization of murine fibroblasts. The
role of this pathway in immortalization of human epithelial cells is not clear. We analyzed the functionality of
the p14ARF-p53 pathway in human mammary epithelial cells (MEC) immortalized by human papillomavirus
16 (HPV16) E6, the p53 degradation-defective E6 mutant Y54D, or hTERT. E6-MEC or E6Y54D-MEC
maintains high-level expression of p14ARF. Late-passage hTERT-immortalized MEC express p53 but down-
regulate p14ARF. Enforced expression of p14ARF induces p53-dependent senescence in hTERT-MEC, while both
E6-MEC and E6Y54D-MEC are resistant. We show that E6Y54D inhibits p14ARF-induced activation of p53
without inactivation of the p53-dependent DNA damage response. Hence, p53 degradation and inhibition of
p14ARF signaling to p53 are independent functions of HPV16 E6. Our observations imply that long-term
proliferation of MEC requires inactivation of the p14ARF-p53 pathway.
After extensive growth in cell culture, primary cells cease
proliferating and develop the phenotype called replicative se-
nescence. Replicative senescence is associated with telomere
shortening and involves p53- and p16ink4a-dependent mecha-
nisms (reviewed in reference 31). Expression of the catalytic
component of telomerase, hTERT, activates telomerase, re-
stores telomeres, and immortalizes some but not all human
cells (7, 26, 39, 47).
When placed in culture, primary human mammary epithelial
cells (MEC) senesce in two stages. The first is characterized by
growth arrest at about 10 population doublings (PDs) and is
termed selection or M0 (4, 16). Selection appears to be con-
trolled by the p16ink4a-pRb pathway, as cells can be rescued
from M0 by expression of human papillomavirus type 16
(HPV16) E7 (16). Some MEC spontaneously lose p16ink4a
expression (8, 17, 22) and give rise to postselection cells. Post-
selection MEC can be propagated further to about 40 PD until
they reach replicative senescence or M1, which can be over-
come by expression of HPV16 E6 (5, 42). Postselection, but
not preselection, MEC can be also immortalized by hTERT
(26), indicating the critical role of telomerase in overcoming
replicative senescence. It has been proposed that HPV16 E6
and E7 induce human epithelial cell immortalization by stim-
ulating hTERT expression and blocking the p16ink4a-pRb path-
way, respectively (26). MEC grown on feeder layers do not
manifest M0 and can be immortalized by hTERT without
inactivation of p16ink4a (21).
The contribution of p53 inactivation to epithelial cell im-
mortalization is complex. Two dominant-negative (dn) p53
mutations immortalize MEC, while the majority of mutations
do not (9, 20). dn p53 together with E7 immortalizes human
foreskin keratinocytes (39, 40). This suggests that the role of
E6 is to degrade and inactivate p53, while E7 blocks the
p16ink4a-Rb pathway. Apart from targeting p53 for degrada-
tion, E6 induces telomerase (27) and also has other biological
activities affecting cell growth (reviewed in reference 38). In-
duction of telomerase by E6 is associated with transcriptional
activation of the hTERT gene (48). Several E6 mutants defec-
tive in p53 degradation (8S9A10T, F2V, and Y54H) can acti-
vate telomerase and immortalize postselection MEC (18, 26,
30). Cells immortalized by these E6 mutants have an intact
DNA damage response to actinomycin D (AcD); therefore,
elimination of p53 protein or the DNA damage checkpoint is
not required for immortalization (26, 30). p14ARF and its mu-
rine counterpart p19ARF inhibit Mdm2-mediated proteolysis of
p53 and thereby increase p53 protein levels (6, 46, 50). Inac-
tivation of p19ARF elicits immortalization in murine embryonic
fibroblasts (MEF) (24, 41); however, the role of p14ARF in
immortalization of human cells is not clear. Pre-M1 MEC
transduced with hTERT, wild-type E6, or E6 mutant 8S9A10T
maintain expression of p14ARF, suggesting that elimination of
p14ARF is not required for immortalization (26).
In this study, we analyzed induction of hTERT by E6 and
expression levels of p14ARF and p16ink4a genes in early and late
passages of MEC transduced with hTERT, E6, or E6 mutant
Y54D. Like Y54H, this E6 mutant does not induce p53 deg-
radation (30). We found that, in comparison to primary MEC,
early passages of E6-MEC, E6Y54D-MEC, and hTERT-MEC
did not alter expression of p14ARF and p16ink4a. In contrast,
late passages of MEC immortalized by hTERT down-regu-
lated p14ARF and p16ink4a, indicating negative selection against
cells expressing these genes. MEC immortalized by E6 or
E6Y54D, while down-regulating p16ink4a to different extents,
maintained high levels of p14ARF expression, implying that these
cells are resistant to p14ARF inhibition. Based on these observa-
tions, we sought to further explore the role of p14ARF in MEC
immortalization and the activities of HPV16 E6 in this process.
MATERIALS AND METHODS
Retroviral vectors and infections. Constructs of HPV16 E6 and various E6
mutants in pLXSN were described before (30); pBabe-puro-hTERT was from R.
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Weinberg; pWZL-hygro and pWZL-Hygro-H-Ras(V12) were from S. Lowe; and
pBabe-puro-p14ARF was from G. Peters. The p14ARF cDNA sequence from
pBabe-puro-p14ARF was recloned as a 0.4-kb BamHI-EcoRI fragment into
pWZL-hygro. The R248W dn p53 mutant from pBabe-puro-p53R248W was
transferred as a BamHI fragment into pLXSN. The LinX-A amphotropic pack-
aging cells were kindly provided by G. Hannon. For production of infectious
virus, LinX-A cells were plated in DFCI-1 media (4) and were transfected with
FuGene6 (Roche). Retrovirus-containing media was harvested 3 days posttrans-
fection of LinX-A cells cultured at 31°C.
Mammary cell immortalization. Normal human MEC strain 76N, generously
supplied by V. Band, and immortal cells derived from it were grown in DFCI-1
media (D media) as described earlier (4). 76N MEC were transduced by infec-
tion with retrovirus supernatant containing pLXSN-16E6, pLXSN-16E6Y54D,
or pBabe-puro-hTERT. MEC were infected for 12 h at 31°C and were trans-
ferred to 37°C. Cells were selected with the appropriate antibiotic 48 h postin-
fection (G418, 75 g/ml, 14 days; puromycin, 0.5 g/ml, 6 days; and hygromycin,
50 g/ml, 3 days). MEC were expanded as two populations. One was always
maintained in D media, and the other was propagated for 18 PD in D2 media,
which is a defined medium lacking serum and bovine pituitary extract and is
selective for immortal MEC (5). The PDs calculated for immortal cells corre-
spond to their outgrowth after antibiotic selection.
Induction of p53 response by AcD. Late-passage immortal MEC were plated
at 106 cells per 10-cm dish 24 h before treatment with AcD (0.5 nM). The cells
were harvested for protein and RNA analysis 24 h posttreatment.
RNA purification. Cells were grown to 70% confluence, were washed twice
with ice-cold phosphate-buffered saline, and were lysed with 4 M guanidinium
thiocyanate, and total RNA was extracted by acid phenol-chloroform (10). The
integrity of the RNA was verified by 1.2% agarose gel electrophoresis with 7%
formaldehyde. Poly(A) RNA was purified from total RNA with an Oligotex
mRNA Kit (Qiagen).
cDNA synthesis and RT-PCR. Single-stranded cDNA was made from 0.3 g of
poly(A) RNA or 1 g of total RNA with Superscript II reverse transcriptase
(RT) (Gibco) with random primer dN6. cDNA was amplified with Taq polymer-
ase (Gibco). The following primer pairs were used: glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)-G3S (dACCACAGTCCATGCCATCAC) and G3A
(dTCCACCACCCTGTTGCTGTA); p14ARF-p14S1 (dGTTCTTGGTGACCC
TCCGGATT) and p14A2 (dATCAGCACGAGGGCCACAG); p16ink4a-p16S1
(dGCCCAACGCACCGAATAGTT) and p16A1 (dGGGCAGTTGTGGCCCT
GTAG); and hTERT-TERT1784S (dCGGAAGAGTGTCTGGAGCAA) and
TERT1928A (dGGATGAAGCGGAGTCTGGA).
Quantitative RT-PCR. cDNA was amplified in the real-time PCR cycler
(SmartCycler; Cepheid) by using PCR buffer supplemented with 1.5 mM MgCl2,
5% dimethyl sulfoxide, 0.1 SYBR Green (S-7563; Molecular Probes), 1
additive reagent (Cepheid), 0.5 M primers for p14ARF (p14S1 and p16A1) or
GAPDH (G3S and G3A), and Taq polymerase (0.025 U/l; Gibco). p14ARF and
GAPDH sequences in each cDNA were quantitated by comparison to amplifi-
cation of external standards of p14ARF or GAPDH DNA, and the ratio of p14ARF
to GAPDH was calculated. Experiments were repeated twice for each cDNA
sample, and the average ratio of p14ARF/GAPDH was determined.
Northern blots. Poly(A) RNA was resolved in 1.5% agarose–7% formalde-
hyde gel, transferred to GeneScreen (NEN Life Science Products), and hybrid-
ized with 32P-labeled DNA probe at 42°C overnight in solution containing 6
SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 50% formamide, 2
Denhardt’s solution, 100 g of salmon sperm DNA/ml, and 1% sodium dodecyl
sulfate (SDS). The membrane was washed in 1 SSC with 0.1% SDS at 55°C.
Images were analyzed on the PhosphorImager Storm 820 (Molecular Dynamics).
p16ink4a exon 1-specific cDNA was generated by PCR with primers p14S1 and
p14A2 (dATCAGCACGAGGGCCACAG). The DNA was 32P labeled in asym-
metric PCR with p14A2 primer and [-32P]dATP. The GAPDH cDNA probe
was generated by PCR with primers G3S and G3A and 32P-labeled with the
Prime-A-Gene Kit (Promega).
Western blots. Cells were washed twice with ice-cold phosphate-buffered sa-
line and were lysed on plates by scraping in TSG buffer (50 mM Tris-HCl, pH 6.8,
2% SDS, and 10% glycerol). Protein concentrations were determined with a
bicinchoninic acid protein assay (Pierce). Proteins were transferred to Immo-
bilon-P membranes (Millipore) and were processed with the following antibod-
ies: anti-p53 DO-1 (Santa Cruz [1:1,000]); anti-p21 polyclonal (sc-397; Santa
Cruz [1:1,000]); anti-p21 monoclonal (OP64; Oncogene Research [1:250]); anti-
MDM2 (sc-965; Santa Cruz [1:500]); antitubulin (SC-5286; Santa Cruz
[1:4,000]); goat–anti-mouse-horseradish peroxidase (Jackson [1:8,000]); goat–
anti-rabbit-horseradish peroxidase (Jackson [1:8,000]). p14ARF was detected only
with Ab3 (2 g/ml, clone 14P03; NeoMarkers) but not with FL-132 (Santa Cruz),
Ab-1 (Oncogene Sciences), Ab2 (clone 14P02; NeoMarkers), or NB200-11
(Novus). Processed blots were developed with SuperSignal West Dura extended-
duration substrate (Pierce). Images were detected and quantitated with the
LAS-1000 luminescent image analyzer (Fuji).
RESULTS
Induction of hTERT by HPV16 E6 in MEC. HPV16 E6 and
immortalization-competent E6 mutants induce telomerase in
MEC (18, 27). Activation of telomerase by E6 correlates with
increased transcription of hTERT (35, 48). However, the tem-
poral expression of hTERT by E6 mutants defective in p53
degradation was not tested. Figure 1 shows RT-PCR of
hTERT and E6 in early and late passages of MEC transduced
with E6 or the E6 mutant Y54D. In primary 76N MEC infected
with the control LXSN retrovirus, hTERT transcripts were
below detection under these RT-PCR conditions (Fig. 1, lane
2). In MEC transduced with E6 or E6Y54D, induction of the
hTERT gene was detected by PD 6 (Fig. 1, lanes 4 and 8).
There was a further dramatic increase in the amount of
hTERT transcription in late-passage cells (Fig. 1, lanes 6 and
10). Of note, levels of E6 RNA did not change (compare lanes
4, 6, 8, and 10). This suggests that, apart from E6, other
secondary events modulate the level of hTERT in MEC. Sim-
ilar findings were recently reported in primary cervical epithe-
lial cells transduced with E6/E7 oncogenes (2) and in human
foreskin keratinocytes transfected with the HPV16 genome
(45). Based on these observations, we investigated whether
MEC expressing E6 or constitutive hTERT exhibits other ad-
aptations in key pathways during passage beyond senescence
checkpoints.
Expression of p53, p14ARF, and p16ink4a in early and late
passages of MEC transduced with hTERT, E6, or E6 mutant
Y54D. Pre-M1 MEC transduced with hTERT, E6 or E6 mutant
8S9A10T, which does not degrade p53, have high levels of
expression of p14ARF while down-regulating p16ink4a (26).
However, later passages of immortal MEC were not tested in
this report. We analyzed levels of p53, p14ARF, and p16ink4a in
FIG. 1. Induction of hTERT in MEC by HPV16 E6 and E6 mutant
Y54D. Poly(A) RNA was extracted from MEC transduced with re-
combinant retroviruses and was analyzed by RT-PCR for hTERT, E6,
or GAPDH. hTERT RT-PCR products were transferred to Gene-
Screen membranes and were hybridized with a 32P-labeled hTERT
DNA probe generated by asymmetric PCR with primer TERT1928A
and [-32P]dATP. The blot is overexposed to demonstrate a lack of
detectable hTERT transcripts in primary 76N MEC infected with
LXSN retrovirus. “PD” represents PD after selection with G418.
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early (PD 6) and late (PD 51) passages of MEC infected with
retroviruses expressing wild-type E6, E6 mutant Y54D, or
hTERT. To avoid clonal variations, we tested pooled popula-
tions of cells. As expected, MEC expressing E6 had low levels
of p53 protein (Fig. 2, lanes 2 and 3), while both E6Y54D-
MEC (lanes 4 and 5) and hTERT-MEC (lanes 6 and 7) had
levels of p53 similar to those of primary 76N cells. This con-
firms that E6-mediated p53 degradation is not required for
MEC immortalization (26, 30). In each cell population, the
level of p53 protein remained consistent at early or late pas-
sage, suggesting that there is no negative selection against
expression of p53 during propagation of these MEC.
We examined the expression of the p14ARF and p16ink4a
genes by RT-PCR (Fig. 3). The primary 76N strains used in
this study are post-M0 MEC and express detectable p16ink4a
mRNA. A uniform population of preselection 76N cells does
not exist for comparison to determine whether p16ink4a was
down-regulated during their selection. Immortal MEC are se-
lected by culture in D2 media, which lacks serum and bovine
pituitary extract (5). Cell growth in serum-free media may
select a subpopulation of cells. Therefore, in addition to the
MEC selected in D2, we tested late-passage cells that were
propagated in parallel cultures in complete D media. Compar-
ison of 76N MEC (Fig. 3, lane 1) or cells infected with pLXSN
empty vector (lane 2) to early-passage cells revealed a slight
increase in the levels of p14ARF transcript, with p16ink4a levels
only marginally decreased in E6Y54D-MEC and hTERT-
MEC (lanes 3, 4, and 5). A different picture emerged from
analysis of late-passage cells (lanes 6 to 11). Both E6-MEC and
hTERT-MEC down-regulated p16ink4a (lanes 9 and 11), while
E6Y54D-MEC exhibited elevated levels of p16ink4a (lane 10).
Interestingly, E6-MEC (lane 9) and E6Y54D-MEC (lane 10)
both maintained high levels of p14ARF, while hTERT-MEC
(lane 11) down-regulated p14ARF. This pattern of p16ink4a and
p14ARF expression was not dependent on D2 media, as cells
always grown in D media (lanes 6, 7, and 8) had similar levels
of expression (compare p14ARF in lanes 6 and 9; lanes 7 and
10; and lanes 8 and 11).
Another report for which Northern blotting was used did not
detect down-regulation of p14ARF in early-passage (pre-M1)
MEC transduced with hTERT, E6, or the p53 degradation-
defective E6 mutant 8S9A10T (26). Therefore, we tested levels
of p14ARF expression in MEC by Northern blotting (Fig. 4A)
and quantitative real-time RT-PCR (Fig. 4B). Both methods
confirmed that expression of p14ARF was down-regulated in
late-passage hTERT-MEC while being maintained in E6-MEC
and E6Y54D-MEC (Fig. 4A, compare lanes 3 to 5, and B).
Real-time RT-PCR revealed a 15-fold reduction of p14ARF
transcript from early to late passage in hTERT-MEC. We also
confirmed that levels of p14ARF protein in 76N and early- and
late-passage hTERT-immortalized MEC (Fig. 5B, lanes 3, 4,
and 7) were barely detectable with one of five commercially
available antibodies and with use of enhanced high- sensitivity
chemiluminescence, indicating that levels of endogenous pro-
teins are very low. p16ink4a protein was not detected by immu-
noblot in lysates from these cells (data not shown).
Enforced expression of p14ARF in hTERT-MEC induces
p53-dependent senescence. Enforced expression of p19ARF in
MEF or p14ARF in human tumor cell lines induces p53-depen-
dent growth arrest (24, 46). Diploid fibroblasts expressing ex-
ogenous p14ARF develop the enlarged flat-cell morphology
and stain positive for senescence-associated -galactosidase
(SA--gal), similar to that seen in cells in replicative senes-
cence (13, 46, 49). It appears that p14ARF-induced growth
arrest requires intact p53-p21cip1 signaling, because p53/ as
well as p21cip1/ diploid human fibroblasts are resistant to
p14ARF inhibition (49). Accordingly, E6 rescues human diploid
fibroblasts from p14ARF inhibition (13, 46). However, expres-
sion of hTERT in diploid fibroblasts does not rescue these cells
from p14ARF, indicating that p14ARF-induced senescence is a
pathway independent from telomerase (49).
Our RT-PCR data suggest that E6- and E6Y54D-immortal-
FIG. 2. Levels of p53 protein in early and late passages of MEC
transduced with wild-type HPV16 E6, E6 mutant Y54D, or hTERT.
Total cell lysate equal to 20 g of protein was loaded per lane and was
analyzed by Western blotting. p53 protein was detected with DO-1
antibody, and tubulin was used as loading control. PD, PD after ret-
rovirus infection and antibiotic selection; *, a nonspecific band.
FIG. 3. RT-PCR of p14ARF and p16ink4a in early and late passages
of immortal MEC. Cells transduced with specified retroviruses were
grown in D or D2 media and were harvested at different PDs. RNA
was analyzed by RT-PCR: p14ARF- 30 cycles, primers p14S1 and
p16A1; p16ink4a, 34 cycles, primers p16S1 and p16A1; and GAPDH, 20
cycles, primers G3S and G3A. MCF7 cells do not express p14ARF and
p16ink4a due to deletion of the INK4a locus. HeLa cells are from an
HPV18-positive cervical cancer cell line and express p14ARF and
p16ink4a.
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ized MEC can tolerate high levels of p14ARF, while hTERT-
immortalized cells cannot. To test this, we expressed exoge-
nous p14ARF in immortal MEC by means of retrovirus-medi-
ated gene transfer. Cells were infected with pWZL-hygro-
p14ARF or pWZL-hygro control retrovirus. After selection
with hygromycin, cells were harvested at specified days for cell
counts and protein or RNA studies. Figure 5A shows RT-PCR
results for MEC infected with the p14ARF retrovirus. Increased
p14ARF RNA levels are seen after hygromycin selection in
hTERT and E6Y54D-MEC after infection with the p14ARF
virus. Lysates from all cells show increased p14ARF protein
analyzed by Western blotting with the Ab3 antibody after in-
fection with pWZL-hygro-p14ARF retrovirus but not with the
control pWZL-hygro virus (Fig. 5B, lanes 10 to 17).
Proliferation of hTERT-MEC was strongly inhibited by
p14ARF (Fig. 6). By day 6 postinfection (about three PDs),
these cells developed the enlarged flat-cell phenotype with
vacuoles characteristic of senescent MEC. By day 12 postin-
fection, most of the cells had this appearance. In contrast to
induced senescence in human fibroblasts (13, 49), we did not
detect increased SA--gal staining in immortal MEC infected
with p14ARF or activated H-RasV12 (data not shown). Lack of
FIG. 4. Expression of p14ARF is down-regulated in late passages of MEC immortalized by hTERT but is maintained in MEC immortalized by
E6 or E6 mutant Y54D. (A) Northern blot. Poly(A) RNA from specified cells was hybridized with 32P-labeled probes specific for p14ARF or
GAPDH. (B) Quantitative RT-PCR. cDNA was amplified in the real-time PCR cycler with SYBR Green detection of PCR products. p14ARF and
GAPDH sequences in each cDNA were quantitated with external standards, and the ratio of p14ARF to GAPDH was calculated. Experiments were
repeated twice for each cDNA sample, and the average p14ARF/GAPDH ratio is shown.
FIG. 5. Detection of p14ARF RNA and protein in MEC infected with p14ARF retrovirus. (A) RT-PCR detection of p14ARF. Cells were infected
with control pWZL-hygro or pWZL-hygro-p14ARF retrovirus. The day 2 time point is immediately before hygromycin selection was started. p14ARF
sequences were amplified in 30 cycles of RT-PCR with primers p14S1 and p14A2. (B) Western blot of p14ARF. Total cell lysate equal to 50 g
of protein was loaded per lane and was analyzed by Western blot. p14ARF protein was detected with the Neomarkers antibody. Lanes 1 and 2 are
HeLa (positive) and MCF7 (negative) controls. Early-passage primary MEC strain 76N (lane 3) and hTERT immortal MEC at early (lane 4) and
late (lane 7) passage do not express detectable p14ARF protein, which was detectable in wild-type HPV 16 E6 (lanes 5 and 8) and mutant Y54D
(lanes 6 and 9) at both early and late passages. Lanes 10 to 17 used lysates from these cells after infection with control (pWZL-hygro) or
pWZL-hygro-p14ARF retrovirus.
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SA--Gal staining in senescent human epithelial cells was also
noted in other studies (V. Band, personal communication). To
test whether p14ARF-induced growth arrest in hTERT-MEC
is dependent on functional p53, we introduced the dn p53
mutant R248W into hTERT-MEC by retrovirus-mediated
gene transfer. The p53R248W inactivates p53-mediated trans-
activation and extends life span but does not immortalize 76N
MEC (9). When infected with p14ARF retrovirus, the hTERT-
p53R248W-MEC (T53-MEC) cells displayed no growth arrest
and no phenotypic change in comparison to infection with
empty vector (data not shown). This proves that p14ARF-in-
duced growth arrest in hTERT-MEC is p53 dependent.
We also tested the effect of exogenous p14ARF on growth of
MEC immortalized by E6 or E6Y54D. Based on high-level
expression of endogenous p14ARF in late passages of these
cells, we predicted that both E6-MEC and E6Y54D-MEC
would be resistant to exogenous p14ARF. As expected, growth
of E6-MEC was not inhibited by p14ARF (Fig. 6) and there was
no difference in phenotype. Interestingly, proliferation of
E6Y54D-MEC was transiently inhibited by p14ARF. By day 6
postinfection with p14ARF, the E6Y54D-MEC were a mixed
population of small cells and large flat cells mostly without
vacuoles. By day 12 postinfection the population was com-
posed mostly of small cells with a doubling rate identical to
that of wild-type E6. Therefore, enforced expression of p14ARF
in E6Y54D-MEC induces transient growth arrest followed by
rapid outgrowth of cells resistant to p14ARF despite the pres-
ence of normal levels of wild-type p53.
Activation of p53 by p14ARF is inhibited in MEC immortal-
ized by E6 mutant Y54D. p14ARF-induced growth arrest is
associated with the p53 stabilization and accumulation of the
products of p53-responsive genes such as MDM2 and p21cip1
(23, 46). The fact that E6Y54D-MEC rapidly overcome p14ARF-
induced growth inhibition suggests that E6Y54D can inactivate
p14ARF-induced activation of p53.
Figure 7A shows levels of p53, p21cip1, and MDM2 proteins
in cells infected with p14ARF or control retrovirus. Figure 7B,
C, and D depict normalized levels of proteins in comparison to
cells infected with pWZL-hygro virus. In hTERT-MEC there
was a 3.5-fold increase in p53 protein at day 2 postinfection (Fig.
7A, compare lanes 6 and 7, and B), before the cells’ morphol-
ogy changed. This level of p53 was maintained through day 12
postinfection (Fig. 7B). Accumulation of MDM2 (Fig. 7A,
compare lanes 6 and 7, and D) was detected at day 2 postin-
fection and increased sevenfold by day 6, when the cells de-
veloped the large flat-cell senescent phenotype. Accumulation
of p21cip1 (Fig. 7C) was also detected at day 2 postinfection
(compare lanes 6 and 7 in Fig. 7A). Interestingly, at day 6 post-
infection, we reproducibly detected accumulation of smaller
peptides cross-reacting with the p21cip1 antibody (Fig. 7A, lane
8). The relative abundance of these faster-migrating p21cip1-
specific peptides increased further by day 12 postinfection (Fig.
7A, lane 9). These proteins were also detected by a second
p21cip1 monoclonal antibody (data not shown), implying that
they are p21cip1 encoded. A p21cip1 antiserum showed only a
single band at the predicted position (data not shown). Total
FIG. 6. Growth of immortal MEC infected with p14ARF retrovirus. Immortal MEC (PD75) were infected with pWZL-hygro-p14ARF retrovirus
or pWZL-hygro empty vector. After selection with hygromycin, cells were harvested and counted at the specified days postinfection. Day 1 is
when cells were plated for infection. Cells were infected on the next day, designated as day 0. The growth curve is the average of two independent
experiments. Note that this is a semilogarithmic graph.
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levels of p21cip1-specific peptides in hTERT-MEC increased
more than 20-fold by day 12 postinfection (Fig. 7C). In E6-
MEC and T53-MEC infected with p14ARF retrovirus, there was
no accumulation of p21cip1 protein (data not shown).
In contrast to hTERT-MEC, stabilization of p53 or accumu-
lation of MDM2 was not detected in E6Y54D-MEC infected
with p14ARF (Fig. 7A, lanes 3 to 5, and B and D). There was a
2.7-fold increase in levels of p21cip1 in E6Y54D-MEC by day 2
postinfection (Fig. 7C). The abundance of p21cip1 gradually
returned to basal noninduced levels by day 12 postinfection
(Fig. 7A, compare lanes 2 to 5, and C).
AcD-induced DNA damage response in immortal MEC.
Analysis of levels of p53, p21cip1, and MDM2 proteins in cells
infected with p14ARF retrovirus implies that activation of p53 is
blocked in E6Y54D-MEC. p53 is activated in response to di-
verse stress signals (reviewed in reference 3). MEC immortal-
ized by the E6 mutant 8S9A10T, F2V, or Y54H, which does
not degrade p53, have an intact DNA damage response to AcD
(26, 30). Therefore, we tested activation of p53 by AcD in
immortal MEC containing E6, E6Y54D, hTERT, or hTERT
p53R248W (Fig. 8). As expected, there was no accumulation
of p53 or p21cip1 in E6-MEC (compare lanes 2 and 3). Both
E6Y54D-MEC (lanes 4 and 5) and hTERT-MEC (lanes 6 and
7) accumulated p53 and p21cip1 proteins, indicating activation
of p53 and induction of p21cip1. However, E6Y54D-MEC ac-
cumulated less p53 and p21cip1 than did hTERT-MEC, indi-
cating that activation of p53 by AcD may be partially compro-
mised by E6Y54D. In contrast to the response induced by
p14ARF, there was no accumulation of small p21cip1-specific
peptides in hTERT-MEC treated with AcD. Evaluation of p53
stabilization in T53-MEC was not possible due to the large
amounts of p53 protein in cells not treated with AcD. Inter-
estingly, a small degree of p21cip1 induction was still present in
T53-MEC expressing dn p53 mutant R248W (compare lanes 8
and 9), indicating residual p53 function or p53-independent
activation of p21cip1 by AcD.
DISCUSSION
In this study we address the role of the p14ARF-p53 and
p16ink4a-pRb pathways in MEC immortalization. It has been
proposed that replicative senescence is dependent only on
telomere shortening, while the p16ink4a-dependent mechanism
of replicative senescence is an artifact created by inappropriate
growth conditions (36). However, even when MEC are grown
on feeder layers, p16ink4a protein levels are down-regulated in
late passages of MEC (21). Collectively, our data and other
studies (26, 39) indicate negative selection against cells ex-
pressing p16ink4a during immortalization and/or propagation of
MEC and keratinocytes—either grown on feeder layers or not.
Activation of the p16ink4a-pRb pathway represses telomerase
activity in cancer cell lines (11, 12). The inverse correlation
between expression of p16ink4a and hTERT in MEC raises the
question whether down-regulation of p16ink4a can account for
increased levels of hTERT in late passage MEC immortalized
by 16E6 or E6-Y54D.
Studies on the role of ARF in cell immortalization are com-
plicated by the partial overlapping of ARF and p16ink4a genes.
FIG. 7. Accumulation of p53, p21cip1, and MDM2 proteins in p14ARF-infected cells. (A) Cells were infected with p14ARF retrovirus or empty
vector as described in the Fig. 6 legend, and total cell lysates corresponding to 20 g of protein were analyzed by Western blot. The arrow indicates
smaller p21cip1-specific peptides detected with OP64 antibody (Oncogene Research). Virus “V,” empty vector pWZL-hygro. (B to D) Levels of p53,
p21cip1, and MDM2 were quantitated with the LAS-1000 luminescent image analyzer (Fuji) and were normalized to tubulin. Protein levels in cells
infected with the empty vector were set at 1.
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Mutations or deletions in the INK4a locus frequently inactivate
both genes, and disruption of ARF might be due to bystander
effect of selection against p16ink4a. In murine cells, inactivation
of p19ARF leads to immortalization of MEF and pre-B cells (24,
33). Rare selective inactivation of p14ARF with retention of
p16ink4a has been reported in human tumors (19, 34, 44), mel-
anoma cell lines (29), a melanoma-neural system tumor syn-
drome family (37), and a postcrisis clone of human adenoid
epithelial cells immortalized by hTERT (15). These data sug-
gest a role for p14ARF in human cancer and cell transforma-
tion, independent from p16ink4a. The observation that E6-
MEC with inactivated p53 function maintain expression of
p14ARF while down-regulating p16ink4a indicates that inactiva-
tion of p14ARF in hTERT-MEC is not a consequence of selec-
tion against p16ink4a and implies an independent role for
p14ARF in MEC immortalization.
Pre-M1 MEC transduced with hTERT, E6 or E6 mutant
8S9A10T maintain high-level p14ARF mRNA (26), suggesting
that elimination of p14ARF is not required for MEC prolifer-
ation. However, advanced passages of those cells were not
tested. In addition, 76N MEC immortalized by Bmi-1 do not
down-regulate p14ARF protein, as shown by Western blot anal-
ysis (14). In our experiments, the level of endogenous p14ARF
protein in primary and hTERT immortal 76N MEC was below
the detection limit of Western blotting with several commer-
cially available polyclonal and monoclonal antibodies. MEC
immortalized by HPV 16 E6, E6Y54D, and hTERT plus dn p53
had low but detectable p14ARF protein, consistent with the
RT-PCR data. In this study down-regulation of p14ARF RNA is
shown in two independent populations of late-passage
hTERT-MEC. Analysis of the p14ARF expression in other ep-
ithelial cells (and other MEC strains) immortalized by hTERT
will clarify if inactivation of p14ARF is a common event in such
cells.
Enforced expression of p14ARF induces p53-dependent
growth arrest and senescence in hTERT-MEC. This is accom-
panied by accumulation of p53, p21cip1, and MDM2, which is in
agreement with p14ARF-induced senescence in fibroblasts (23,
46, 49). Interestingly, in addition to full-size p21cip1, we found
accumulation of smaller p21cip1-specific peptides. Such pep-
tides are not detected in hTERT-MEC treated by AcD. The
truncated p21cip1 peptides represent amino-terminal fragments
of p21cip1, since the carboxy-terminal p21cip1 polyclonal anti-
serum detects only one full-size p21cip1 in the p14ARF-infected
hTERT-MEC (data not shown). The N terminus of p21cip1 has
cdk inhibitory activity, while the C terminus binds and inhibits
PCNA (32). Other studies have not shown the induction of
p21cip1 fragments in cells expressing exogenous p14ARF but
used different cell strains and antibodies (23, 46, 49). The
origin and significance of the p21cip1-derived peptides are a
subject for further investigation.
Previous studies showed that E6 mutants 8S9A10T, F2V,
and Y54H do not degrade p53 yet could immortalize MEC (26,
30), identical to the phenotype that we show here for E6Y54D.
Interestingly, these mutant E6 proteins all retained ability to
bind the ubiquitin ligase E6AP, which is necessary for E6-
mediated p53 degradation. Pre-M1 MEC expressing these mu-
tants, as well as hTERT-MEC, express normal levels of p53
and p14ARF and preserve the p53-dependent DNA damage
checkpoint. However, here we show that, while cells immor-
talized by E6Y54D express p53, p14ARF signaling to p53 is
inactivated and p14ARF-induced senescence is blocked. None-
theless, cells harboring E6Y54D remain susceptible to p53
activation by DNA damage. p14ARF is not strictly required for
p53-dependent DNA damage response but may modulate it
(25). The mechanism for how E6Y54D restricts p14ARF-in-
duced activation of p53 requires further investigation. Differ-
ent stress signals activate p53 through multiple pathways (3). In
tumor cells, the p53-dependent response to hypoxia-like stress
may be inactivated while response to AcD is intact (1). The
present model is that ARF stabilizes p53 by targeting MDM2
to the nucleolus and blocking p53 ubiquitination by MDM2
(reviewed in reference 43). E6Y54D may block p53 activation
by interaction with the p53 protein or by inhibiting another
protein(s) required for p53 activation. Interestingly, a recent
study shows that immortalization-competent E6 mutants de-
fective in p53 degradation, including E6Y54H, bind and de-
grade the p53 transcriptional coactivator hADA3 (28). We are
currently examining the relationship between E6 binding to
cellular targets and inhibition of the p14ARF-p53 pathway.
The mechanism of E6 stimulation of hTERT expression is of
active interest. We show a dramatic increase in expression of
hTERT in late-passage MEC immortalized by wild-type E6 or
E6Y54D. This was not accompanied by an increase in the level
of E6. Similar findings were reported in human keratinocytes
FIG. 8. Accumulation of p53 and p21cip1 proteins in AcD-treated
cells. (A) Late-passage immortal MEC were treated with AcD, and
total cell lysates (20 g) were analyzed by Western blot as described in
the Fig. 7 legend. (B) Levels of p21cip1 were quantitated and normal-
ized to tubulin as described in the Fig. 7 legend. p21cip1 levels in 76N
cells were set at 1.
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transduced with HPV16 E6/E7 (2). Our observations in MEC
suggest initial E6-dependent induction of low levels of hTERT
followed by E6-independent induction of high levels of hTERT
expression during propagation of cells. Alternatively, different
cells transduced with E6 initially express variable levels of
hTERT, and only those with high levels of expression become
immortal and are selected for during propagation.
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